Pilot analysis of the plasma metabolite profiles associated with emphysematous Chronic Obstructive Pulmonary Disease phenotype

Biochemical and Biophysical Research Communications

Volumn 413, Issue 4, 2011, Pages 588-593

  Paige, Mikell ^a   Burdick, Marie D ^b   Kim, Suhyon ^b   Xu, Junrui ^c   Lee, Jae K ^b   Michael Shim, Y ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c University of Virginia   (United States)

Author keywords

Chronic Obstructive Pulmonary Disease; Emphysema; Metabolite(s); Metabolomics; UPLS QTOF MS

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPHYSEMA; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG FUNCTION TEST; MALE; METABOLITE; METABOLOMICS; PHENOTYPE; PILOT STUDY; PLASMA; PREDICTION; PRIORITY JOURNAL; TIME OF FLIGHT MASS SPECTROMETRY;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; METABOLOME; METABOLOMICS; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING;

EID: 80053586178     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.09.006     Document Type: Article

References (17)

1. MMWR, Deaths from COPD - US-2000-2005, <>, 2008. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a4.htm.
2. Miller J.D., Foster T., Boulanger L., et al. Direct costs of COPD in the US: an analysis of Medical Expenditure Panel Survey (MEPS) data. COPD 2005, 2:311-318.
3. Pauwels R.A., Buist A.S., Ma P., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. Respir. Care 2001, 46:798-825.
4. Sluiter H.J., Koeter G.H., de Monchy J.G., et al. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur. Respir. J. 1991, 4:479-489.
5. Cosio M.G., Guerassimov A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am. J. Respir. Crit. Care Med. 1999, 160:S21-25.
6. Izquierdo J.L., Almonacid C., Parra T., Perez J. Systemic and lung inflammation in 2 phenotypes of chronic obstructive pulmonary disease. Arch. Bronconeumol. 2006, 42:332-337.
7. Raherison C., Girodet P.O. Epidemiology of COPD. Eur. Respir. Rev. Off. J. Eur. Respir. Society 2009, 18:213-221.
8. Postma D.S., Siafakas N.M. Epidemiology of Chronic Obstructive Pulmonary Disease. Eur. Respir. Mon. 1998, 41-73.
9. Halbert R.J., Natoli J.L., Gano A., et al. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J.: Off. J. Eur. Soc. Clinic. Respir. Physiol. 2006, 28:523-532.
10. Koczulla R., Bittkowski N., Andress J., et al. The German registry of individuals with alpha-1-antitrypsin deficiency - a source for research on patient care. Pneumologie 2008, 62:655-658.
11. Stoller J.K., Fromer L., Brantly M., et al. Primary care diagnosis of alpha-1 antitrypsin deficiency: issues and opportunities. Cleve. Clin. J. Med. 2007, 74:869-874.
12. Mulgrew A.T., Taggart C.C., McElvaney N.G. Alpha-1-antitrypsin deficiency: current concepts. Lung 2007, 185:191-201.
13. Nicholson J.K., Wilson I.D., Lindon J.C. Pharmacometabonomics as an effector for personalized medicine. Pharmacogenomics 2011, 12:103-111.
14. Pellegrino R., Viegi G., Brusasco V., et al. Interpretative strategies for lung function tests. Eur. Respir. J.: Off. J. Eur. Soc. Clinic. Respir. Physiol. 2005, 26:948-968.
15. Hurst J.R., Vestbo J., Anzueto A., et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N. Engl. J. Med. 2010, 363:1128-1138.
16. Agusti A., Calverley P.M., Celli B., et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir. Res. 2010, 11:122.
17. Pillai S.G., Kong X., Edwards L.D., et al. Loci identified by genome-wide association studies influence different disease-related phenotypes in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2010, 182:1498-1505.